The Technical Analyst
Select Language :
Akero Therapeutics Inc [AKRO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Akero Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Akero Therapeutics Inc is listed at the  Exchange

3.31% $25.26

America/New_York / 28 mar 2024 @ 16:00


Akero Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 741.61 mill
EPS: -2.89
P/E: -8.74
Earnings Date: May 13, 2024
SharesOutstanding: 68.95 mill
Avg Daily Volume: 1.421 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -8.74 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.49x
Company: PE -8.74 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.96
(-84.32%) $-21.30
Date: 2024-03-28
Expected Trading Range (DAY)

$ 22.63 - 27.85

( +/- 10.36%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-13 Yale Catriona Sell 723 Common Stock
2024-03-13 White William Richard Sell 724 Common Stock
2024-03-13 Cheng Andrew Sell 1 969 Common Stock
2024-03-13 Young Jonathan Sell 651 Common Stock
2024-03-13 Rolph Timothy Sell 619 Common Stock
INSIDER POWER
51.38
Last 100 transactions
Buy: 2 061 541 | Sell: 659 470

Forecast: 16:00 - $25.22

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $25.22
Forecast 2: 16:00 - $25.22
Forecast 3: 16:00 - $25.22
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $25.26 (3.31% )
Volume 0.851 mill
Avg. Vol. 1.421 mill
% of Avg. Vol 59.94 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Akero Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Akero Therapeutics Inc

RSI

Intraday RSI14 chart for Akero Therapeutics Inc

Last 10 Buy & Sell Signals For AKRO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$18.53N/AActive
Profile picture for
            Akero Therapeutics Inc

AKRO

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
ZRXUSDMar 28 - 21:11$1.016
PROUSDMar 28 - 21:08$2.26
LEOUSDMar 28 - 21:086.03
ICPUSDMar 28 - 21:06$18.06
SANTOSUSDMar 28 - 20:587.76
FXSUSDMar 28 - 20:59$7.71
KUBUSDMar 28 - 20:582.77
KCSUSDMar 28 - 20:58$12.06
BCHUSDMar 28 - 21:00$568.09
STRAXUSDMar 28 - 20:55$0.141

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.